Invention Grant
US08772287B2 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
有权
嘧啶基和1,3,5-三嗪基苯并咪唑磺酰胺及其在癌症治疗中的应用
- Patent Title: Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
- Patent Title (中): 嘧啶基和1,3,5-三嗪基苯并咪唑磺酰胺及其在癌症治疗中的应用
-
Application No.: US13914385Application Date: 2013-06-10
-
Publication No.: US08772287B2Publication Date: 2014-07-08
- Inventor: Gordon William Rewcastle , Swarnalatha Akuratiya Gamage , Jack Urquhart Flanagan , Anna Claire Giddens , Kit Yee Tsang
- Applicant: VetDC, Inc.
- Applicant Address: US CO Fort Collins
- Assignee: VetDC, Inc.
- Current Assignee: VetDC, Inc.
- Current Assignee Address: US CO Fort Collins
- Agency: Swanson & Bratschun LLC
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D251/54
Abstract:
Provided herein are pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides, e.g., compounds of Formulae IA, IB, and IC, and their pharmaceutical compositions, preparation, and use as agents or drugs for cancer therapy, either alone or in combination with radiation and/or other anticancer drugs.
Public/Granted literature
- US20130289016A1 PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLE SULFONAMIDES AND THEIR USE IN CANCER THERAPY Public/Granted day:2013-10-31
Information query
